Inicio › Enfermedad de obstrucción pulmonar crónica › California
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en California
27 estudios sobre Enfermedad de obstrucción pulmonar crónica buscan participantes en California.
Ciudades en California
- Los Angeles9 estudios
- Newport Beach8 estudios
- San Francisco5 estudios
- Santa Monica3 estudios
- Long Beach3 estudios
- Buena Park3 estudios
- Santa Clarita3 estudios
- San Diego3 estudios
Texto oficial del estudio (inglés)
Digital Inhaler Use in Obstructive Lung Disease Care
- Cedars-Sinai Medical Center, Los Angeles
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07214337A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50021, Encino
- Copd01 50016, Westminster
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 6 nov 2026 · NCT07725939A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- NewportNativeMD, Inc., Newport Beach
- Institute of HealthCare Assessment d/b/a Apex Clinical Research, San Diego
ReclutandoFase 2
Edades de 40 a 75 · Todos los sexos · Actualizado el 5 nov 2026 · NCT07759245To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Leading Edge Research, LLC, Encino
- California Medical Research Associates Inc., Northridge
ReclutandoFase 2
Edades de 40 a 85 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07684820Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
- Zuckerberg San Francisco General (ZSFG) Hospital, San Francisco
- Maxine Hall Health Center (MHHC), San Francisco
- Southeast Health Center (SEHC), San Francisco
Reclutando
Edades de 40 a 90 · Todos los sexos · Actualizado el 27 oct 2026 · NCT05572632A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 100, Los Angelas
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 26 oct 2026 · NCT07555483A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Los Angeles
- Research Site, Newport Beach
- Research Site, Norco
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07082738Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Ark Clinical Research- Site Number : 8400113, Long Beach
- Inglewood Clinical- Site Number : 8400074, Los Angeles
- Alliance Clinical - West Hills- Site Number : 8400067, Los Angeles
- y 1 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07190222A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Los Angeles
ReclutandoFase 2
Edades de 40 a 80 · Todos los sexos · Actualizado el 23 oct 2026 · NCT07646587A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- IMAX Clinical Trials, La Palma
- NewportNativeMD, Inc., Newport Beach
- California Medical Research Associates, Northridge
- y 1 más
ReclutandoFase 2/3
Edades de 35 a 80 · Todos los sexos · Actualizado el 22 oct 2026 · NCT07363694Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of California at Davis, Sacramento
Reclutando
Edades de 40 a 84 · Todos los sexos · Actualizado el 19 oct 2026 · NCT06891755Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- IMAX Clinical Trials- Site Number : 8400109, La Palma
- Long Beach Research Institute- Site Number : 8400027, Long Beach
- Downtown L.A. Research Center- Site Number : 8400009, Los Angeles
- y 3 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 19 oct 2026 · NCT07190209STRIVE Post-Market Registry Study
- El Camino, Taft Center for Clinical Research, Mountain View
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 oct 2026 · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- University of California, San Francisco, San Francisco
Reclutando
Edades de 22 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT07119229A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Palo Alto
- Research Site, Redding
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06878261Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Bakersfield
- GSK Investigational Site, Modesto
- GSK Investigational Site, Newport Beach
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Castroville
- Research Site, Garden Grove
- Research Site, Inglewood
- y 12 más
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06283966Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of San Francisco, San Francisco
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Garden Grove
- Research Site, Newport Beach
- Research Site, Torrance
ReclutandoFase 3
Edades de 40 a 80 · Todos los sexos · Actualizado el 3 sept 2026 · NCT06883305Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of California, Los Angeles, Los Angeles
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 31 jul 2026 · NCT06376994eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Newport Beach
ReclutandoFase 3
Edades de 40 a 75 · Todos los sexos · Actualizado el 28 jul 2026 · NCT07177339Lung Macrophage Populations and Functions in Chronic Obstructive Pulmonary Disease (COPD)-Susceptible Smokers
- San Francisco VA Medical Center, San Francisco
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 jun 2026 · NCT04722835The Cardiovascular Consequences of Sleep Apnea Plus COPD (Overlap Syndrome)
- UCSD Sleep Research, La Jolla
ReclutandoFase 2
Edades de 40 a 79 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05237505SPIROMICS Study of Early COPD Progression (SOURCE)
- University of California Los Angeles, Los Angeles
- University of California, San Francisco, San Francisco
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 a 55 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05033990PiMZ Longitudinal Cohort (PiMZ Logic)
- University of California- Los Angeles, Los Angeles
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 ene 2026 · NCT06505603Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Science 37, Los Angeles
ReclutandoEstudio observacional
Edades de 50 en adelante · Todos los sexos · Actualizado el 5 ago 2025 · NCT06122077Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
- Arthur F Gelb MD, Lakewood
- Arthur F Gelb MD, Lakewood
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 30 en adelante · Todos los sexos · Actualizado el 27 oct 2023 · NCT03263130De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.